VRTX

Vertex Pharmaceuticals
D

VRTX

397.15
USD
0.58
(0.15%)
Market Closed
Volume
432,538
EPS
0
Div Yield
-
P/E
-207
Market Cap
102,277,757,524
Related Instruments
    AMGN
    AMGN
    2.27
    (0.87%)
    263.46 USD
    BIIB
    BIIB
    -0.780
    (-0.53%)
    146.590 USD
    B
    BMRN
    0.695
    (1.07%)
    65.680 USD
    E
    EXEL
    -0.390
    (-1.16%)
    33.280 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    I
    INCY
    1.910
    (2.85%)
    68.910 USD
    I
    IONS
    0.040
    (0.11%)
    35.630 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    More
News

Title: Vertex Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Vertex Pharmaceuticals is an American biopharmaceutical company in the business of researching, developing, manufacturing and marketing small molecule drugs for human patients with serious diseases. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, Massachusetts. Some of the diseases impacted by its therapies include cystic fibrosis; infectious diseases, including viral infections, such as influenza and bacterial infections; rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders. The company was one of the early pioneers of rational drug design rather than combinatorial chemistry.